Guest guest Posted April 2, 2009 Report Share Posted April 2, 2009 From: JOE & JOANIE LAMENSKIE Date: 4/2/2009 8:08:22 PM To: Breathe-Support@yahoogrou Subject: TRIAL MEDS HI GANG, Per conversation on the chat, here is the info on the trial drug. ARTEMIS: a phase 3, randomized, double-blind, placebo controlled, multi-center, parallel group, event driven study to evaluate the efficacy and safety of Ambrisentan in subjects with early Idiopathic Pulmonary Fibrosis (IPF). The company sponsoring is Gilead Sciences Inc. They are located in Seattle, Washington Protocol no: GS-US-231-0101 WRIB Protocol #20081290 W00000067 The study is 1-3 years. I was informed the study will begin in the next 4-6 weeks. I will receive a call next week to fill me in on schedule. As I learn more I will keep ya'll informed. I enjoyed chat tonight. It is nice to hear voices of fellow comrades with this stupid disease. Hope all is well, Joe JOE & JOANIE LAMENSKIE IPF JAN. 2008 -- I missed the Chat I am sorry that I missed the Chat tonight. I wish I could have heard all of your voices. Hope everyone is doing well. I started back to my exercise class yesterday after a month of bronchitis and 20 days of Avelox + one steroid shot. Today I was on the Nustep for 30 minutes, arm bicycle for ten minutes and treadmill for 10 minutes = 50 minutes. Yesterday I was on the bicycle for 20 minutes, treadmill for 10 minutes, Nustep for 10 minutes and arm bicycle for 10 minutes = 50 minutes. I feel better today. Toodles! Jane UIP/IPF 12/1998 Dalton, Georgia aka pianolady_musicgirl Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 2, 2009 Report Share Posted April 2, 2009 Gosh I hope tomorrow is a better day for you. 60mg is miserable. Here's hoping. S > > > > /*From:*/ JOE & JOANIE LAMENSKIE > > /*Date:*/ 4/2/2009 8:08:22 PM > > /*To:*/ Breathe-Support@yahoogrou Breathe-Support > > > /*Subject:*/ TRIAL MEDS > > > > > > > > > > > > HI GANG, > > Per conversation on the chat, here is the info on the trial drug. > > ARTEMIS: a phase 3, randomized, double-blind, placebo controlled, > > multi-center, parallel group, event driven study to evaluate the > > efficacy and safety of Ambrisentan in subjects with early Idiopathic > > Pulmonary Fibrosis (IPF). The company sponsoring is Gilead Sciences Inc. > > They are located in Seattle, Washington > > Protocol no: GS-US-231-0101 > > WRIB Protocol #20081290 > > W00000067 > > The study is 1-3 years. > > I was informed the study will begin in the next 4-6 weeks. I will > > receive a call next week to fill me in on schedule. As I learn more I > > will keep ya'll informed. > > I enjoyed chat tonight. It is nice to hear voices of fellow > > comrades with this stupid disease. > > > > Hope all is well, > > > > Joe > > > > > > JOE &JOANIE LAMENSKIE > > IPF JAN. 2008 > > > > > > > > > > > > /--*/ I missed the Chat > > > > > > I am sorry that I missed the Chat tonight. I wish I could have heard > > all of your voices. Hope everyone is doing well. I started back to > > my exercise class yesterday after a month of bronchitis and 20 days of > > Avelox + one steroid shot. > > > > Today I was on the Nustep for 30 minutes, arm bicycle for ten minutes > > and treadmill for 10 minutes = 50 minutes. Yesterday I was on the > > bicycle for 20 minutes, treadmill for 10 minutes, Nustep for 10 > > minutes and arm bicycle for 10 minutes = 50 minutes. I feel better today. > > > > Toodles! > > > > Jane UIP/IPF 12/1998 Dalton, Georgia aka pianolady_musicgirl > > > > > > > > > > > > > > Free Animations for your email - by IncrediMail! Click Here! > > http://www.incredimail.com/?id=600876&rui=110113153> > > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.